TMR + CABG Trial Data Reveal Little About Procedure’s Efficacy – MCAC
This article was originally published in The Gray Sheet
Executive Summary
CMS should work with other HHS agencies to develop a new randomized trial comparing TMR + CABG to bypass alone, according to the Medicare Coverage Advisory Committee
You may also be interested in...
Renal Denervation Researcher Argues Sham Control Is Ethically Necessary
The lead investigator on the SYMPLICITY HTN-3 trial says sham-controlled trials are sometimes ethically necessary to prevent patients from undergoing ineffective treatments and warns there may be other medical devices on the market that are not as effective as previously thought.
TMR + CABG Coverage To Continue, CMS Informs Thoracic Surgeons Society
Medicare carriers may continue to cover laser transmyocardial revascularization concurrent with coronary artery bypass surgery, according to CMS
TMR + CABG Coverage To Continue, CMS Informs Thoracic Surgeons Society
Medicare carriers may continue to cover laser transmyocardial revascularization concurrent with coronary artery bypass surgery, according to CMS